Skip to main content
  • Mohammad Al Tarrass

     In August 2024, Mohammad joined the EnVI Laboratory as a Postdoctoral Researcher for the EU-funded EIC Pathfinder project, MIMOSA
     
     Mohammad AlTarrass    
     PhD in Cell Biology
     LinkedIn: Mohammad-al-tarrass ; ORCID: 0009-0003-9337-9100
     

    Biography

    Mohammad Al Tarrass is a passionate early-stage researcher with a strong background in biochemistry, cell biology, and expertise in vascular biology. He holds a Bachelor's degree in Biochemistry from Lebanese University and completed a double diploma Master’s degree in Healthy Living Technologies with honors in 2019, through a collaborative program between Lebanese University (Lebanon) and the University of Grenoble Alpes (France). During this program, he performed his Master's internship at the Biomics Lab (CEA Grenoble), where he investigated the DNA-dependent protease SPRTN as a therapeutic target in cancer.

    Following this, Mohammad began his PhD at CEA Grenoble-Biosanté, working within the BMP family in the angiogenesis and lymphangiogenesis team (BAL). His research focused on deciphering phosphoproteomic changes in response to BMP9 and BMP10 in endothelial cells. The aim was to understand the role of these ligands in vascular homeostasis and propose novel therapeutic approaches for treating rare vascular diseases, particularly Hereditary Hemorrhagic Telangiectasia (HHT) and Pulmonary Arterial Hypertension (PAH), which are associated with defects in their signaling pathways. He successfully obtained his PhD in Cell Biology from the University of Grenoble Alpes in 2023.

    Throughout his scientific career, Mohammad has gained significant experience in various aspects of cellular biology, utilizing a wide range of molecular and biochemical techniques alongside advanced technologies (Mass-spectrometry). He has published three scientific papers, a book chapter, and presented his research at several national and international conferences (Researchgate).

    In addition to his role in the MIMOSA project, Dr Al Tarrass is developing and validating, together with Dr Thomas Duflot, an analytical method for analyzing sphingosine and sphingosine-1-phosphate (S1P) species in biological samples (in vivo or in vitro models of cardiovascular disease) using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). He will also investigate the role of S1P signaling in vascular endothelial cells and its significance in maintaining vascular and lymphatic barriers. This work builds on ongoing international projects led by the EnVI laboratory, including ANR PHASM (Dr Jeremy Bellien) and ANR CITE-LYMPH (Dr Ebba Brakenhielm).

    Read more

  • ERA4Health CARDINNOV HFpEF-DIVA

    Proudly presenting ERA4Health project HFpEF-DIVA Consortium (2024-2027):  Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling

     Ebba web  vanessa web  Arantxa webb  Liz webb  hybrigenics web  Krista web

    Dr Ebba Brakenhielm

    Coordinator:
    EnVI Laboratory,
    INSERM UMR1096
    Rouen, France              

    Dr Vanessa van Empel

    Partner 2: 
     Maastricht University
    Department of Cardiology, CARIM, Netherlands

    Pr Arantxa González-Miqueo

    Partner 3:
    CIMA,
    Pamplona, Spain   

       . 

    Pr Elizabeth Jones

    Partner 4: 
    KU Leuven,
    Belgium

      

     

    Dr Jean-Christophe Rain

    Partner 5: Hybrigenics SAS, Evry, France

       

     

    Krista Bogaert

    Collaborator I:
     Healthy Heart Fund, Leuven, Belgium

     

    Read more: ERA4HEALTH Joint Action 

    Twitter / X: #HFpEF_DIVA 

    Read more

  • ERA4Health CARDINNOV GANDHI

    Proudly presenting ERA4Health project GANDHI Consortium (2024-2027):

    O-GlucNAse in Acute Decompensated Heart Failure. From Bench to Bed-Side

    paul mulder  csm florence pinet  Nabben Miranda 2  Stefan Chlopicki

    Pr Paul MULDER

    Co-ordinator, Partner 1: EnVI Laboratory,
    INSERM UMR1096, Rouen, France                

    Dr Florence PINET

    Partner 2: INSERM U1167,
    Institut Pasteur Lille, France         

     Dr Miranda NABBEN

    Partner 3: Maastricht University, 
    Department of Cardiology,
    CARIM, Netherlands

    Pr Stefan CHLOPICKI

    Partner 4: Jagiellonian University,
    Krakow, Poland

    Read more: ERA4HEALTH Joint Action

    Read more

  • New review out in ATVB

    ATVB 2024New review article on cardiac lymphatics published in ATVB

    Read more

  • Offre d'emploi: Gestionnaire administratif

    Nous cherchons a recruter un/une Chargé-e de gestion administrative et d'aide au pilotage opérationnel - J2C46 (BAP J, IGE)

    Mission 1 : responsable administratif et financier

    Mission 2 : gestion des ressources humaines

    Mission 3 : gestion et suivi des projets de recherche

    Savoir / connaissances 

    Savoir faire / compétences opérationnelles

    Voir procedure sur: La communauté universitaire - Liste des postes BIATSS publiés au mouvement interne au fil de l'eau (univ-rouen.fr)

    Read more

Inserm U1096 - Laboratory EnVI

u1096-2014small

Research performed in Inserm U1096 Unit in Rouen, concerns evaluation of the mechanisms behind and novel treatments of cardiovascular diseases, focusing on vascular protection and improvement of cardiac contractile function. This research is transversal, and performed both in experimental models and in human.

EnVI lab (@INSERMU1096) / Twitter

2014

2020

2023